Thioglycine and l-thiovaline: Biologically active H2S-donors

Bioorganic & Medicinal Chemistry
2012.0

Abstract

Thioglycine and l-thiovaline are stable under acidic and basic conditions but in the presence of bicarbonate they liberate the gasotransmitter H(2)S. In cells both thioamino acids were proven to enhance cGMP formation and promote vasorelaxation in mouse aortic rings. Given that H(2)S is known to lower arterial hypertension, reduce oxidative stress and exhibit cardioprotective effects in preclinical models, H(2)S donors hold promise as novel treatments for cardiovascular diseases.

Knowledge Graph

Similar Paper

Thioglycine and l-thiovaline: Biologically active H2S-donors
Bioorganic & Medicinal Chemistry 2012.0
Design, Synthesis, and Cardioprotective Effects ofN-Mercapto-Based Hydrogen Sulfide Donors
Journal of Medicinal Chemistry 2015.0
1,2,4-Thiadiazolidin-3,5-diones as novel hydrogen sulfide donors
European Journal of Medicinal Chemistry 2018.0
Acyloxy Nitroso Compounds as Nitroxyl (HNO) Donors: Kinetics, Reactions with Thiols, and Vasodilation Properties
Journal of Medicinal Chemistry 2011.0
Toxicity, bioactivity, release of H2S in vivo and pharmaco-kinetics of H2S-donors with thiophosphamide structure
European Journal of Medicinal Chemistry 2019.0
2-Arylidene Hydrazinecarbodithioates as Potent, Selective Inhibitors of Cystathionine γ-Lyase (CSE)
ACS Medicinal Chemistry Letters 2017.0
Synthesis and Pharmacological Evaluation of Novel Adenine–Hydrogen Sulfide Slow Release Hybrids Designed as Multitarget Cardioprotective Agents
Journal of Medicinal Chemistry 2016.0
Toxicities and beneficial protection of H<sub>2</sub>S donors based on nonsteroidal anti-inflammatory drugs
MedChemComm 2019.0
O<sup>2</sup>-Sulfonylethyl Protected Isopropylamine Diazen-1-ium-1,2-diolates as Nitroxyl (HNO) Donors: Synthesis, β-Elimination Fragmentation, HNO Release, Positive Inotropic Properties, and Blood Pressure Lowering Studies
Journal of Medicinal Chemistry 2012.0
Cytoprotective effects of hydrogen sulfide-releasing N-methyl-<scp>d</scp>-aspartate receptor antagonists mediated by intracellular sulfane sulfur
MedChemComm 2014.0